2022
DOI: 10.1007/s00270-022-03222-y
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Thrombectomy in Patients with Occlusions of the Aortoiliac Segment: A Case Series

Abstract: Objective Thrombectomy of the aortoiliac segment remains a challenge for surgical and endovascular revision. This study aimed to evaluate the concept of percutaneous thrombectomy in patients with aortoiliac segment occlusions. Materials & Methods Eighteen patients with aortoiliac occlusion who underwent percutaneous thrombectomy were retrospectively identified using the local picture archive and divided into the stent-graft (N = 10) and native vessels … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…The benefit of percutaneous thrombectomy in acute aortoiliac occlusive disease is the rapid ability to remove a large amount of clot burden and rapidly establish reperfusion which is beneficial for patient prognosis and limb salvage. 7 The Inari ClotTriever an endovascular mechanical thrombectomy devise designed to remove large thrombi and emboli in a single session without the need for thrombolytics. 8 The ClotTriever was found to be safe and effective in treating acute and nonacute lower extremity DVTs.…”
Section: Discussionmentioning
confidence: 99%
“…The benefit of percutaneous thrombectomy in acute aortoiliac occlusive disease is the rapid ability to remove a large amount of clot burden and rapidly establish reperfusion which is beneficial for patient prognosis and limb salvage. 7 The Inari ClotTriever an endovascular mechanical thrombectomy devise designed to remove large thrombi and emboli in a single session without the need for thrombolytics. 8 The ClotTriever was found to be safe and effective in treating acute and nonacute lower extremity DVTs.…”
Section: Discussionmentioning
confidence: 99%